Lamivudine loaded microspheres for oral use: Design, development and establishment of invivo-invitro correlation

Asian Journal of Pharmaceutical and Clinical Research

Volumn 2, Issue 1, 2009, Pages 55-60

  Shankar, Nayak Bhabani ^a   Kumar, Nayak Udaya ^b  

^a Jeypore College of Pharmacy   (India)

^b NONE

Author keywords

Dissolution rate; In vivo parameters; In vivo in vitro correlations; Release kinetics

Indexed keywords

LAMIVUDINE; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARTICLE SIZE; RABBIT; SCANNING ELECTRON MICROSCOPY; TABLET FORMULATION;

EID: 77953435418     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bajaj A, Desai M. Challenges and strategies in novel drug delivery technologies. Pharma Times 2006;38:12-16.
2. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotype and the response to interferon therapy. J. Hepatol. 2000;33:998-1002.
3. Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia, Controller of Publications, New Delhi; 1996.
4. Perry CM and Faulds D. Lamivudine- A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs 1997;53 : 667-680.
5. Chien YW. Concept and system design for rate controlled drug delivery. In: Novel drug delivery systems. Marcel Dekker, New York; 1992.
6. Li Y, Jiang HL, Zhu KJ, Liu JH, YL Hao. Preparation, Characterization and nasal delivery of á-cobrotoxin-loaded poly (lactide-co-glycolide) / polyanhydride Microspheres. J. Control. Release 2005;108:10-20.
7. FDA Guidance for Industry: Waiver of invivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms containing certain active moieties/active ingredients based on biopharmaceutics classification system; 1999.
8. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/ evaporation: reviewing the state of art of microsphere preparation process technology, J. Control.Release (2005) 102(7):313-332
9. Gowda DV, Shivakumar HG. Encapsulation of griseofulvin in wax / fat Microspheres: Preparation, characterization and release kinetics of microspheres. Indian Drugs 2005; 42: 453-460
10. Izza AK, Tambrallo L, Lu RD. In vivo evaluation of zidovudine (AZT)-loaded Ethylcellulose microspheres after oral administration in Beagle Dogs. J. Pharm. Sci. 1997;86:554-559.
11. Reddy KR, Mutalik S, Reddy S. Once daily-sustained release matrix tablets of nicorandil: Formulation and invivo evaluation. AAPS Pharm. Sci. Tech. 2003;4:E61.
12. Ishii K, Saitou Y, Yamada R, Itai S, Nemoto M. Novel approach for determination of correlation between invivo and invitro dissolution using the optimization technique. Chem. Pharm. Bull. 1996;44:1550-1555.
13. Gohel MC, Parik RK, Amin AF, Surati AK. Preparation and formulation optimization of sugar cross-linking gelatin microspheres of diclofenac sodium. Indian J. Pharm. Sci. 2005;67:575-581.
14. Abu IK, Gracia CL, Robert LD. Preparation and evaluation of zidovudine-loaded sustained-release microspheres. J. Pharm. Sci. 1996;85(6):575-576.
15. Kulkarni GT, Gowthamarajan K, Suresh B. Stability testing of pharmaceutical products: an over view. Indian J. Pharm. Edu. Res. 2004;38:194-202.
16. Banker GS, Rhodes CT. Modern Pharmaceutics. 2nd ed. Marcel Dekker Inc. (NY); 1990.
17. Morkhade DM, Fulzele SV, Satturwar PM, Joshi SB. Gum copal and gum dammar: novel matrix forming material for sustained drug delivery. Indian J. Pharm. Sci. 2006;68:53-58.
18. Higuchi T. Mechanism of rate of sustained-action medication. J. Pharm. Sci. 1963;52:1145-1149
19. Bolton S. Analysis of variance. In: Pharmaceutical statistics-practical and clinical application. Marcel Dekker NY; 1997.